Application 062798
- Type
- ANDA
- Sponsor
- ISTITUTO BIO ITA SPA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OXACILLIN SODIUM | OXACILLIN SODIUM | INJECTABLE;INJECTION | EQ 1GM BASE/VIAL | No | No |
| 002 | OXACILLIN SODIUM | OXACILLIN SODIUM | INJECTABLE;INJECTION | EQ 2GM BASE/VIAL | No | No |
| 003 | OXACILLIN SODIUM | OXACILLIN SODIUM | INJECTABLE;INJECTION | EQ 125MG BASE/VIAL | No | No |
| 004 | OXACILLIN SODIUM | OXACILLIN SODIUM | INJECTABLE;INJECTION | EQ 250MG BASE/VIAL | No | No |
| 005 | OXACILLIN SODIUM | OXACILLIN SODIUM | INJECTABLE;INJECTION | EQ 500MG BASE/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A062798-001 | OXACILLIN SODIUM | OXACILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | ||
| A062798-002 | OXACILLIN SODIUM | OXACILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | ||
| A062798-003 | OXACILLIN SODIUM | OXACILLIN SODIUM | EQ 125MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | ||
| A062798-004 | OXACILLIN SODIUM | OXACILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | ||
| A062798-005 | OXACILLIN SODIUM | OXACILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A062798-001 | OXACILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A062798-002 | OXACILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A062798-003 | OXACILLIN SODIUM | EQ 125MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A062798-004 | OXACILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A062798-005 | OXACILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A062798-001 | OXACILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A062798-002 | OXACILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A062798-003 | OXACILLIN SODIUM | EQ 125MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A062798-004 | OXACILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A062798-005 | OXACILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A062798-001 | OXACILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A062798-002 | OXACILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A062798-003 | OXACILLIN SODIUM | EQ 125MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A062798-004 | OXACILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A062798-005 | OXACILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A062798-001 | OXACILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A062798-002 | OXACILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A062798-003 | OXACILLIN SODIUM | EQ 125MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A062798-004 | OXACILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A062798-005 | OXACILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A062798-001 | OXACILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A062798-002 | OXACILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A062798-003 | OXACILLIN SODIUM | EQ 125MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A062798-004 | OXACILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A062798-005 | OXACILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A062798-001 | OXACILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A062798-002 | OXACILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A062798-003 | OXACILLIN SODIUM | EQ 125MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A062798-004 | OXACILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A062798-005 | OXACILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A062798-001 | OXACILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A062798-002 | OXACILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A062798-003 | OXACILLIN SODIUM | EQ 125MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A062798-004 | OXACILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A062798-005 | OXACILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A062798-001 | OXACILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A062798-002 | OXACILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A062798-003 | OXACILLIN SODIUM | EQ 125MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A062798-004 | OXACILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A062798-005 | OXACILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 1995-12-11 | 6a51e52b5d6a… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxacillin | OXACILLIN SODIUM | Eugia US LLC | 81e90279-9889-47bd-974b-334c181f295c | 2025-08-13 | Warnings, Adverse reactions | OXACILLIN SODIUM |
| Oxacillin | OXACILLIN SODIUM | Eugia US LLC | 152758c0-d225-4761-abeb-3f1cb0190806 | 2025-08-13 | Warnings, Adverse reactions | OXACILLIN SODIUM |
| Oxacillin | OXACILLIN SODIUM | Fresenius Kabi USA, LLC | 9d37aae5-78d6-4b72-832a-7152c3a7068e | 2020-07-31 | Warnings, Adverse reactions | OXACILLIN SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.